These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 74626)
21. Increased D-glucaric acid excretion in children with renal disease. Németh I; Szeleczki T Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):357-60. PubMed ID: 7409939 [TBL] [Abstract][Full Text] [Related]
22. Exposure to toluene increases the urinary excretion of D-glucaric acid. Moretto A; Lotti M Br J Ind Med; 1990 Jan; 47(1):58-61. PubMed ID: 2310708 [TBL] [Abstract][Full Text] [Related]
23. An evaluation of urinary D-glucaric acid excretion during acute hepatitis in man. Carrella M; D'Arienzo A; Manzillo G; De Ritis F Am J Dig Dis; 1978 Jan; 23(1):18-22. PubMed ID: 619622 [No Abstract] [Full Text] [Related]
24. Phenobarbitone-induced urinary excretions of D-glucaric acid and 6beta-hydroxycortisol in man. Latham AN; Turner P; Franklin C; Maclay W Can J Physiol Pharmacol; 1976 Oct; 54(5):778-82. PubMed ID: 991005 [TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of D-glucaric of D-glucaric acid determination in the urine of porphyria cutanea tarda patients]. Adjarov D; Kerimova M; Ivanov E; Naidenova E Dermatol Monatsschr; 1985; 171(4):233-5. PubMed ID: 2861119 [No Abstract] [Full Text] [Related]
26. Increased urinary D-glucaric acid excretion by children living in an area polluted with tetrachlorodibenzoparadioxin (TCDD). Ideo G; Bellati G; Bellobuono A; Mocarelli P; Marocchi A; Brambilla P Clin Chim Acta; 1982 Apr; 120(3):273-83. PubMed ID: 7074964 [TBL] [Abstract][Full Text] [Related]
36. Effect of phenobarbitone on hepatic drug-metabolizing enzymes and urinary D-glucaric acid excretion in man. Lecamwasam DS; Franklin C; Turner P Br J Clin Pharmacol; 1975 Jun; 2(3):257-62. PubMed ID: 1234506 [TBL] [Abstract][Full Text] [Related]
37. Correlation between the level of urinary D-glucaric acid and the degree of activation of masked compound (FT-207) in cancer patients. Matsuoka S; Maezawa S; Sakuma M; Ohira S; Wakui A; Saito T Tohoku J Exp Med; 1981 Nov; 135(3):281-90. PubMed ID: 6797104 [TBL] [Abstract][Full Text] [Related]
38. Urinary excretion of D-glucaric acid, an indicator of drug metabolizing enzyme activity, in patients with impaired renal function. Kampf D; Roots I; Hildebrandt AG Eur J Clin Pharmacol; 1980 Oct; 18(3):255-61. PubMed ID: 7439245 [TBL] [Abstract][Full Text] [Related]